- Industry
- 2 min read
Listerine-maker Kenvue beats estimates on strong essential health product sales
​Investor expectations from the consumer health company, which Johnson & Johnson spun off last year, have been low due to weak uptake for its self-care and skin health products. Its essential health business, however, has been a bright spot.
Shares of the company rose 4.7 per cent to $19.05 in premarket trading.
Investor expectations from the consumer health company, which Johnson & Johnson spun off last year, have been low due to weak uptake for its self-care and skin health products. Its essential health business, however, has been a bright spot.
The essential health unit recorded $1.26 billion in revenue for the second quarter, up nearly 5 per cent from a year earlier and above analysts' average estimate of $1.24 billion, according to LSEG data.
Essential health's adjusted operating income jumped nearly 44 per cent to $359 million, while other segments declined.
Kenvue's skin health business, which sells brands such as Neutrogena and Clean & Clear, was the worst performer, recording a nearly 4 per cent decline in sales to $1.10 billion, compared with LSEG estimate of $1.16 billion.
Sales from self-care - its largest segment that houses Benadryl and Tylenol - slipped 1.6 per cent to $1.64 billion. Analysts, on average, had expected $1.60 billion.
Kenvue has been focusing on improving sales of its skin health products through increased marketing spend and in-store presence, among other measures.
It raised the marketing spend for this year to up to $400 million from $300 million previously. It's the second time it lifted the forecast, after a 15 per cent jump in February.
The New Jersey-based company posted total second-quarter revenue of $4 billion, above LSEG estimates of $3.94 billion.
On an adjusted basis, Kenvue posted a profit of 32 cents per share, beating analysts' estimates by 4 cents.
The company maintained its adjusted profit forecast for the year at between $1.10 and $1.20 per share. (Reporting by Sneha S K and Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions